Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

NCT00400504 · clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Rigshospitalet, Denmark